Exhibit 99.1 THE LGL GROUP, INC. REPORTS FIRST QUARTER 2025 RESULTS ORLANDO, Florida (May 15, 2025) The LGL Group, Inc. (NYSE American: LGL) ("LGL," "LGL Group," or the "Company") announced today its financial results for the first quarter ended March 31, 2025. Results from Operations Total revenues increased $30,000 to $918,000 for the three months ended March 31, 2025 from $888,000 for the three months ended March 31, 2024 primarily due to higher shipments in the Electronic Instruments segment. Backlog As ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F _________________ (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report For the transition period from to Commission file number 001-33283 EUROSEAS LTD. (Exact name of Registrant as specified in its charter) Not applicable (Translatio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________________ to __________________________ Commission file number: 001-40970 TRUGOLF HOLDINGS, INC. (Exact name of registrant as specified in its c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________________ to __________________________ Commission file number: 001-40970 TRUGOLF HOLDINGS, INC. (Exact name of registrant as specified in its c ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File No. 001-00106 The LGL Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delawa ...

Exhibit 99.1 Maui Land & Pineapple Company, Inc. Reports Fiscal First Quarter 2025 Results and Announces New Scalable Agri-Business Venture KAPALUA, Hawai'i / May 15, 2025 (BusinessWire) – Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the quarter ended March 31, 2025. The Company also announced a new agriculture-based business venture designed to maximize the value of currently underutilized croplands and stimulate economic revitalization on Maui. Additional updat ...

Financial Performance - For the three months ended March 31, 2025, the company reported a net loss of $3.9 million, compared to a net income of $0.6 million for the same period in 2024, representing a 711% increase in loss [196]. - The company did not generate any revenue during the three months ended March 31, 2025 and 2024, with future revenue dependent on successful drug development and commercialization [197]. - As of March 31, 2025, the company had an accumulated deficit of $120.0 million and cash of $1.261 million, raising concerns about its ability to operate for at least 12 months [204][210]. Expenses - Research and development expenses decreased by $0.7 million to $0.325 million for the three months ended March 31, 2025, a 68% reduction compared to $1.0 million in 2024 [196][201]. - General and administrative expenses increased by $0.8 million to $2.633 million for the three months ended March 31, 2025, a 40% increase from $1.879 million in 2024 [196][202]. - Net cash used in operating activities decreased by $1.1 million, from $2.8 million in Q1 2024 to $1.7 million in Q1 2025, representing a 40% reduction [215]. - The company expects to incur additional costs associated with operating as a public company following the merger, impacting future cash flow requirements [213]. - The company anticipates increased expenses related to preclinical activities and clinical trials for product candidates, particularly for ABP-102 and ABP-201 [213]. Funding and Financing - The company raised $11.2 million through a private placement of 3,367,401 shares of common stock concurrent with the merger [192]. - The company intends to seek additional funding through equity and debt financings, collaboration agreements, and research grants to support its operations [210]. - Net cash provided by financing activities decreased by $2.2 million, from $2.3 million in Q1 2024 to $0.1 million in Q1 2025, a decline of 94% [216]. - The company plans to finance cash needs through equity offerings, debt financings, and collaborations, which may dilute ownership interests [214]. - The company may need to delay or scale back product development if unable to raise additional funds through various financing methods [214]. Corporate Developments - A merger with Atlantic Costal Acquisition Corp. II was completed on November 13, 2024, resulting in the company being renamed Abpro Holdings, Inc. [191]. - The company is under scrutiny from Nasdaq for failing to meet the minimum bid price requirement of $1.00 per share and the market value of publicly held shares requirement of $15 million [206][207]. Intellectual Property - The company is focused on maintaining and expanding its intellectual property portfolio, which involves costs related to patent claims and disputes [213]. Other Financial Information - The increase in accounts payable was approximately $0.7 million in Q1 2025 compared to a decrease of $0.4 million in Q1 2024, affecting cash flow timing [215]. - The company received proceeds of $0.1 million from the settlement of the Forward Purchase Agreement in Q1 2025 [216]. - The company’s financial statements are prepared in accordance with US GAAP, requiring estimates that may differ from actual results [217].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-41224 Abpro Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware 85-1013956 | | | | -- ...

Financial Performance - Net income for the first quarter was $163.8 million, or $10.39 per share, down from $180.0 million, or $11.09 per share in the prior year[2] - Total net sales decreased to $1.529 billion from $1.549 billion, while total retail sales (excluding construction business) fell 2% to $1.468 billion[3][4] - Comparable store sales decreased by 1% during the same period[4] - Retail gross margin was 45.5% of sales, down from 46.2% in the previous year[5][6] - Operating expenses were $421.7 million, representing 27.6% of sales, slightly up from 27.5% in the prior year[5][8] - Inventory increased by 6% compared to the previous year[7] Stock and Investments - The company repurchased $98 million in stock, reducing total shares outstanding to 15.6 million[9] - Cash and short-term investments totaled $1.2 billion after stock repurchases[1] Store Operations - The company operates 272 stores across 30 states, totaling 46.3 million square feet[10] Capital Expenditures - Estimated capital expenditures for 2025 are projected at $120 million, up from $105 million in 2024[14] Risk Management and Economic Outlook - The company is monitoring potential impacts on consumer spending patterns and economic changes[16] - Risks and uncertainties are detailed in periodic reports filed with the SEC, particularly in the Annual Report on Form 10-K for the fiscal year ended February 1, 2025[16] - The company emphasizes the importance of understanding demographic changes that may affect its operations[16] - The company is committed to addressing risks outlined under "Item 1A, Risk Factors" in its annual filings[16] - Future strategies will be influenced by ongoing economic and demographic trends[16] - The company is focused on maintaining transparency regarding its financial health and risk management[16] - The company plans to adapt its business strategies in response to identified risks and uncertainties[16] - The company is actively engaged in assessing the potential impact of market changes on its performance[16] - The company will continue to provide updates on its financial outlook and risk factors in future reports[16] - The company is dedicated to ensuring accurate and timely communication with stakeholders regarding its financial status[16]

Revenue and Losses - Revenue for the three months ended March 31, 2025, was $979,977, compared to $0 for the same period in 2024, indicating a significant increase[12] - Net loss for the three months ended March 31, 2025, was $(11,495,947), compared to $(9,995,136) for the same period in 2024, representing an increase in losses[12] - For the nine months ended March 31, 2025, the company reported a net loss of $36.6 million, compared to a net loss of $29.1 million for the same period in 2024, indicating a 26% increase in losses year-over-year[21] - The company reported a net loss per share of $(0.14) for the three months ended March 31, 2025, compared to $(0.19) for the same period in 2024[12] Expenses and Financial Performance - Gross loss for the three months ended March 31, 2025, was $(2,689,960), while the gross loss for the nine months ended March 31, 2025, was $(8,003,944)[12] - Total operating expenses for the nine months ended March 31, 2025, were $26,245,059, compared to $25,433,780 for the same period in 2024, reflecting a slight increase[12] - The company incurred stock-based compensation expenses of $12.8 million for the nine months ended March 31, 2025, compared to $12.3 million in the same period of 2024[21] - Stock-based compensation expense for the period reached $6,330,914, contributing to the overall financial performance[15] Assets and Liabilities - Cash and cash equivalents as of March 31, 2025, were $2,849,257, down from $7,001,786 as of June 30, 2024[9] - Total current assets increased to $23,285,228 as of March 31, 2025, compared to $18,406,048 as of June 30, 2024[9] - Total liabilities decreased to $10,851,323 as of March 31, 2025, from $16,207,492 as of June 30, 2024[9] - Stockholders' equity increased to $65,605,927 as of March 31, 2025, compared to $61,467,640 as of June 30, 2024[9] Inventory and Production - As of March 31, 2025, the total inventory was $252,945,000, an increase from $154,320,000 as of June 30, 2024, representing a growth of 63.9%[49] - The cost of goods sold for the three months ended March 31, 2025, was $3.7 million, significantly exceeding the related revenue, attributed to the depreciation of fixed assets and production process finalization[36] - The Company expects the high cost of goods sold to continue rising but to decrease as a percentage of revenue as production scales and efficiencies are gained[36] Financing and Capital Structure - The company issued 8,773,586 common shares and warrants pursuant to registered direct offerings, raising $13,911,000[16] - The company completed an At-The-Market offering, resulting in the issuance of 5,938,786 shares, raising $6,327,168[15] - The Company’s shareholders approved an increase in authorized shares from 80 million to 250 million, allowing for the reclassification of derivative liabilities totaling $2.1 million to additional paid-in capital[62] - The Company has authorized a total of 250,000,000 shares of common stock as of March 31, 2025, following an amendment to increase the number of authorized shares[93] Grants and Tax Credits - The Company was awarded a tax credit of up to $40.5 million through the 48C program for a new battery recycling facility in the U.S.[56] - The Company received a grant award of $144 million from the U.S. DOE for the construction of a lithium-ion battery recycling facility, with cumulative funds invoiced totaling $0.2 million as of March 31, 2025, representing 0.2% of total eligible reimbursements[57] - The Company recognized $4.3 million of invoiced government funds as an offset to research and development costs during the nine months ended March 31, 2025[50] Operational Challenges and Future Outlook - The company has a significant reliance on obtaining debt or equity financing to continue operations, with substantial doubt regarding its ability to continue as a going concern for the next 12 months[25] - The company is focused on increasing domestic production of critical battery materials and developing new technologies for extraction and recycling of lithium-ion batteries[22] - The continuation of the company as a going concern is dependent on generating profit from operations and obtaining financing, with substantial doubt existing regarding its ability to continue for the next 12 months[25] Shareholder and Stock Activity - The weighted average shares outstanding increased to 85,090,957 for the three months ended March 31, 2025, from 51,993,863 for the same period in 2024[12] - The total unvested share awards as of March 31, 2025, were 7,816,136, with a weighted average grant date fair value of $2.18 per unit[110] - The Company issued 14,360,308 total warrants during the nine months ended March 31, 2025, including 3,548,426 warrants from a private placement[106] Depreciation and Impairment - The Company recognized a depreciation expense of $3.8 million for the nine months ended March 31, 2025, significantly higher than $121,075 in the previous year[21] - The Company recognized a depreciation expense of $1.2 million for the three months ended March 31, 2025, compared to $39,665 for the same period in 2024[65] - An impairment charge of $10.3 million was recorded on assets held-for-sale for the fiscal year ended June 30, 2024[67]